Key terms

About COR

Cencora, Inc. is a pharmaceutical sourcing and distribution services company. It operates through the United States (U.S.) Healthcare Solutions and International Healthcare Solutions segments. The U.S. Healthcare Solutions segment focuses on the distribution of specialty, brand-name, and generic pharmaceuticals. The International Healthcare Solutions segment includes pharmaceutical wholesale, related operations, and global commercialization services. The company was founded by Emil P. Martini in 1947 and is headquartered in Conshohocken, PA.

Sector
Industry
Employees
Founded
Website
Key stock statistics
1-day range
     
52-week range
     
Market cap
P/E ratio
Next earnings date
Dividend yield
Ex-dividend date
Dividend pay date

Key terms

Smart score

Latest COR news

Mar 13 6:41am ET Analysts Offer Insights on Healthcare Companies: Cencora (COR), Cormedix (CRMD) and NeueHealth Inc (NEUE) Mar 13 6:30am ET Analysts Have Conflicting Sentiments on These Healthcare Companies: Cencora (COR) and Clearside Biomedical (CLSD) Mar 12 9:03am ET Cencora Announces CEO Change, Reaffirms 2024 Financial Outlook Mar 12 8:39am ET Cencora backs FY24 adjusted EPS view $13.25-$13.50 from $12.70-$13.00 Mar 12 8:36am ET Cencora CEO Steven Collis to retire, Robert Mauch to succeed Feb 26 7:10am ET Analysts Conflicted on These Healthcare Names: Cencora (COR), Alkermes (ALKS) and Intellia Therapeutics (NTLA) Feb 26 6:20am ET Cencora initiated with an Outperform at Leerink Feb 14 10:01am ET FTC probing drug distributors over low supplies of chemotherapies, WSJ reports Feb 10 4:29am ET Cencora Significant Share Sale Alters Ownership Stake Feb 10 4:28am ET Cencora Buys Back Shares to Boost Shareholder Value Feb 08 4:29am ET Cencora Receives Legal Opinion on Note Validity Feb 08 4:29am ET Cencora Closes Notes Offering, Attracts Investor Interest Feb 08 4:29am ET Cencora Establishes New Direct Financial Commitment Feb 08 4:29am ET Cencora Secures $500M in Senior Notes Offering Feb 07 6:28pm ET Cencora announces common share repurchase from Walgreens Boots Alliance Feb 05 1:20pm ET Analysts Conflicted on These Healthcare Names: Cencora (COR) and Morphosys Ag (MOR) Feb 05 1:08pm ET Cencora price target raised to $235 from $213 at Wells Fargo Feb 05 7:44am ET Cencora price target raised to $224 from $192 at Mizuho Feb 01 7:37am ET Cencora price target raised to $261 from $215 at TD Cowen Feb 01 7:18am ET Cencora price target raised to $267 from $251 at UBS Feb 01 6:34am ET Cencora price target raised to $261 from $232 at Baird Feb 01 5:47am ET Cencora price target raised to $263 from $242 at Barclays Feb 01 5:03am ET Analysts’ Opinions Are Mixed on These Healthcare Stocks: Thermo Fisher (TMO) and Cencora (COR) Jan 31 4:55pm ET Cencora’s Strong Earnings Momentum and Operational Vigor Prompt a Buy Rating Jan 31 8:20am ET Analysts Are Bullish on These Healthcare Stocks: Stryker (SYK), Cencora (COR) Jan 31 6:33am ET Cencora raises FY24 adjusted EPS view to $13.25-$13.50 from $12.70-$13.00 Jan 31 6:31am ET Cencora reports Q1 adjusted EPS $3.28, consensus $2.89 Jan 24 7:00am ET Cencora price target raised to $247 from $221 at JPMorgan Jan 11 1:45am ET Cencora’s Strong Position and Expansion Plans Bolster Buy Rating with New Price Target Jan 08 10:10am ET Cencora price target raised to $240 from $220 at Argus Jan 03 9:55am ET Early notable gainers among liquid option names on January 3rd Jan 03 6:19am ET Barclays starts healthcare technology, distribution with Neutral view

No recent news articles are available for COR

No recent press releases are available for COR

COR Financials

1-year income & revenue

Key terms

COR Forecasts

analyst rating

  • buy
  • hold
  • sell

We're sorry, but this
information is
temporarily unavailable.

1-year stock price forecast

COR Competitors

$ Market cap P/E ratio $ Price 1d change 52-week range

Key terms